Go beyond the FDA approval headlines and into the REAL business of psychedelic medicine. While most eyes are on the drug developers, venture capitalist Maria Velkova shares where the smart money is going. The Tabula Rasa Ventures managing partner tells the untold story of the critical infrastructure needed for psychedelics to succeed post-approval, Big Pharma’s recent entry into the space, the maturation of the industry beyond the hype, and the massive commercial hurdles that many are overloo...
All content for Evolving Minds By Pink Elephant is the property of Pink Elephant Team and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Go beyond the FDA approval headlines and into the REAL business of psychedelic medicine. While most eyes are on the drug developers, venture capitalist Maria Velkova shares where the smart money is going. The Tabula Rasa Ventures managing partner tells the untold story of the critical infrastructure needed for psychedelics to succeed post-approval, Big Pharma’s recent entry into the space, the maturation of the industry beyond the hype, and the massive commercial hurdles that many are overloo...
The Psychedelic Gold Rush Is Over? Big Pharma, AI, and Psychedelic Research Inside the NHS
Evolving Minds By Pink Elephant
50 minutes
2 months ago
The Psychedelic Gold Rush Is Over? Big Pharma, AI, and Psychedelic Research Inside the NHS
Go inside the REAL business of psychedelic medicine. While everyone talks about investment and FDA headlines, George McBride is on the front lines doing the essential work. The Clerkenwell Health co-founder reveals the untold story of navigating psychedelic clinical trials, Big Pharma’s growing interest, public-private partnerships with the NHS, the future of AI in psychedelic clinical trials, and much more. A candid and insightful look at innovation, regulation, and what it really takes to b...
Evolving Minds By Pink Elephant
Go beyond the FDA approval headlines and into the REAL business of psychedelic medicine. While most eyes are on the drug developers, venture capitalist Maria Velkova shares where the smart money is going. The Tabula Rasa Ventures managing partner tells the untold story of the critical infrastructure needed for psychedelics to succeed post-approval, Big Pharma’s recent entry into the space, the maturation of the industry beyond the hype, and the massive commercial hurdles that many are overloo...
